# | ||||
---|---|---|---|---|
1 | BASAL BREAST CANCER Characterization of myoepithelial differentiation in basal-like breast cancer cells | 2008 | 169˙390.00 | 169˙390.00 |
2 | SYNTHLE BRCA Synthetic lethality approaches to BRCA-associated cancer | 2008 | 169˙390.00 | 169˙390.00 |
3 | HER2 MAMMARYSTEMCELL The influence of Her2 status on mammary stem/progenitor cells | 2009 | 0.00 | 171˙867.00 |
4 | PARYLOME pARylation-mediated regulation of cancer pathways | 2011 | 30˙000.00 | 30˙000.00 |
5 | MELANOMA INVASION Molecular mechanisms of melanoma invasion | 2011 | 209˙592.00 | 209˙592.00 |
6 | ICRMYELOMA Sequence of Mutational Events and Sub-clonal Architecture in Plasma Cell Myeloma | 2012 | 209˙033.00 | 209˙033.00 |
7 | TAMIRCRT Targeting microRNAs for ColoRectal Cancer Therapy | 2013 | 100˙000.00 | 100˙000.00 |
8 | LIVERNCODE Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer | 2013 | 100˙000.00 | 100˙000.00 |
9 | CDELP CHD1 Deletion: Implications to Outcome and Treatment in Prostate Cancer | 2014 | 231˙283.00 | 231˙283.00 |
10 | RESICT-PC Studying Resistance to Cancer Therapeutics in Prostate Cancer | 2014 | 231˙283.00 | 231˙283.00 |
11 | BARCODE The use of genetic profiling to guide prostate cancer targeted screening and cancer care | 2014 | 2˙499˙123.00 | 2˙499˙123.00 |
L'Ente institute of cancer research - royal cancer hospital partecipato anche in questi progetti.